New study aims to sharpen virus diagnosis in the elderly

NCT ID NCT07239830

Recruiting now Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is measuring natural immune markers called interferons in healthy adults aged 80 and older. The goal is to establish normal reference values, which could help doctors better distinguish between active viral infections and past ones. Researchers will collect nasal swabs and blood samples from 62 participants during a single visit.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better diagnose respiratory viral infections in older adults by providing age-specific reference values for immune markers.
What could go wrong: This is an observational study with only 62 participants, so results may not apply to all older adults. It does not test any treatment or intervention.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNOSENESCENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IMMUNOSENESCENCE UNINFECTED OLDER

Contacts and locations

Locations

Hôpital des Charpennes (Hospices Civils de Lyon)
RECRUITING

Villeurbanne, 69100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.